CJC-1295 with DAC and Ipamorelin Interaction

Monitor
Researched 90% confidence

CJC-1295 with DAC and Ipamorelin have an interaction requiring monitoring for interaction with 90% confidence. Continuous GH elevation may reduce synergistic benefits of pulsatile protocols. Both compounds affect the gi tract and pituitary, so monitoring these systems is recommended.

Compound Profiles

CJC-1295 with DAC

Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release

DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..

Half-life: 6-8 days Typical dose: 1-2mg weekly growth hormone, weight loss
ghrh receptorigf1 carcinogenic riskestrogenicinsulin disrupting
View full profile

Ipamorelin

Growth Hormone Secretagogue | Selective GHRP

Binds selectively to ghrelin receptors in pituitary gland, stimulating natural GH release with direct systemic delivery via injection, consistent GH pulse stimulation, no significant cortisol or prolactin elevation, and minimal hunger response..

Half-life: ~2 hours Typical dose: 200-300 mcg per injection growth hormone, weight loss, sleep
ghrelin receptorprolactin receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Brain
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (CJC-1295 with DAC, Ipamorelin). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (CJC-1295 with DAC, Ipamorelin). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take CJC-1295 with DAC with Ipamorelin?

Yes, but with caution. Continuous GH elevation may reduce synergistic benefits of pulsatile protocols. Regular monitoring is advised.

Is CJC-1295 with DAC and Ipamorelin safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting. Monitor accordingly.

What are the interactions between CJC-1295 with DAC and Ipamorelin?

Continuous GH elevation may reduce synergistic benefits of pulsatile protocols. This assessment has 90% confidence and is based on documented research data.

How should I time CJC-1295 with DAC and Ipamorelin?

CJC-1295 with DAC has a half-life of 6-8 days and Ipamorelin has a half-life of ~2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 with DAC vs Ipamorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.